Credicorp Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Credicorp Ltd. covers the month of June 2011, specifically reporting a material event dated June 28, 2011. The registrant is a Bermuda-based company filing under Form 20-F. The report notifies the U.S. Securities and Exchange Commission and the Peruvian securities regulator (CONASEV) of a strategic acquisition by a subsidiary.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity figures for the period. The document focuses exclusively on a corporate transaction.
Material Changes and Transactions
The primary material event is an acquisition agreement signed on June 28, 2011, by Pacífico S.A. Entidad Prestadora de Salud (Pacífico EPS). Key details include:
- Acquirer: Pacífico EPS, a subsidiary of El Pacífico Peruano Suiza Compañía de Seguros y Reaseguros.
- Ownership Structure: El Pacífico Peruano Suiza is 75.98% owned by Credicorp Ltd. and 21.57% owned by Grupo Credito SA (a wholly-owned subsidiary of Credicorp).
- Targets:
- Not less than 70% of the shares of La Esperanza del Peru S.A.
- 100% of the shares of Analisis Clinicos ML S.R.L.
- Conditions: The acquisition is subject to certain conditions that must be met prior to closing.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, or an outlook for future periods. The primary contingency noted is that the acquisition is conditional upon meeting specific requirements. No other risks or unusual items are disclosed in this text.
Investor Verification Checklist
- Verify the specific conditions precedent required to close the acquisition of La Esperanza del Peru S.A. and Analisis Clinicos ML S.R.L.
- Confirm the final ownership percentage of Credicorp Ltd. in the acquired entities post-closing.
- Review subsequent filings for updates on the regulatory approval status of the transaction.
- Assess the strategic fit of these health insurance and clinical analysis assets within Credicorp's broader portfolio.